We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
Insulin aspart
From Proteopedia
(Difference between revisions)
| Line 2: | Line 2: | ||
Insulin aspart, sold under the brand name NovoLog and Fiasp, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. See also [https://en.wikipedia.org/wiki/Insulin_aspart]. | Insulin aspart, sold under the brand name NovoLog and Fiasp, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. See also [https://en.wikipedia.org/wiki/Insulin_aspart]. | ||
| - | <scene name='96/968809/Cv/4'> | + | <scene name='96/968809/Cv/4'>Hexamer of the human insulin variant B28Asp at pH 6.5</scene> (PDB ID [[4gbc]]). |
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 12:23, 6 June 2023
| |||||||||||
